DRMAW vs SPCE
Dermata Therapeutics Inc. Warrant (DRMAW) versus Virgin Galactic Holdings Inc (SPCE) — a side-by-side from cached financials, not a winner call.
Dermata Therapeutics Inc. Warrant (DRMAW) common stock listed on NASDAQ.
Virgin Galactic Holdings Inc (SPCE) is a aerospace & defense company listed on NYSE.
DRMAW does not have a complete income-statement cache yet.
Latest reported SPCE revenue for 2026-06-30 was $361.0K. Net income was -$120.6M. Revenue was up 59.0% from 2026-03-31 to 2026-06-30. SPCE currently screens at market cap $388.0M.
DRMAW currently screens at market cap $0. SPCE currently screens at market cap $388.0M.
Not investment advice. Open the DRMAW and SPCE stock pages for the full models.
Not investment advice.